AI assistant
Sending…
Sarepta Therapeutics, Inc. — Director's Dealing 2012
Sep 11, 2012
31721_dirs_2012-09-11_0f9a4356-13b5-4926-8082-299cd0db8052.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2012-09-07
Reporting Person: BEHRENS M KATHLEEN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-07 | Common Stock | P | 9700 | $14.58 | Acquired | 28866 | Direct |
| 2012-09-07 | Common Stock | P | 7800 | $14.91 | Acquired | 36666 | Direct |
More from Sarepta Therapeutics, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4